{"id":"W2755296718","doi":"10.1136/annrheumdis-2017-eular.2326","title":"FRI0230 Retention rates of tnf inhibitors and abatacept used as a first biologic dmard in the treatment of rheumatoid arthritis: 8 years of experience from the rhumadata® registry","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Osteoporosis Canada; Bristol-Myers Squibb (Canada); Montreal Clinical Research Institute","funders":"","keywords":"Adalimumab; Medicine; Golimumab; Abatacept; Infliximab; Etanercept; Internal medicine; Rheumatoid arthritis; Discontinuation; Certolizumab pegol; Tumor necrosis factor alpha; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01199453,0.000297244,0.001218747,0.001084389,0.0005263323,0.001974912,0.001273284,0.0009067851,0.002160967],"category_scores_gemma":[0.01784636,0.0003386918,0.001575819,0.002311234,0.0006165237,0.001551049,0.001057592,0.001157434,0.001207602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001549248,"about_ca_system_score_gemma":0.002038313,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02227212,"about_ca_topic_score_gemma":0.01462487,"domain_scores_codex":[0.9917405,0.003095109,0.001250574,0.001041004,0.002113285,0.0007595373],"domain_scores_gemma":[0.9814903,0.005558508,0.006597015,0.002366535,0.002968136,0.001019629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004868844,0.0004269253,0.9623715,0.0001607484,0.0006302932,0.0002465021,0.0008493828,0.0003235387,0.0005467513,0.0002034788,0.003471813,0.0259002],"study_design_scores_gemma":[0.0003001699,0.001034327,0.9910572,0.00006693725,0.0004593154,0.0005722736,0.0007609986,0.0006666929,0.0004972803,0.00005279944,0.004482201,0.00004982502],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984167,0.005056599,0.0003851196,0.0003754428,0.00003929658,0.00003681739,0.007674373,0.00004460452,0.002220652],"genre_scores_gemma":[0.9874472,0.001538055,0.0003074089,0.0002206853,0.0000604608,0.00004254935,0.009304008,0.00004884424,0.001030776],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02227212,"threshold_uncertainty_score":0.06343389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0626517723474842,"score_gpt":0.3396250807231176,"score_spread":0.2769733083756334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}